Last reviewed · How we verify
Prilosec OTC™ Tablets
Prilosec OTC works by reducing the amount of acid produced in the stomach.
Prilosec OTC works by reducing the amount of acid produced in the stomach. Used for Treatment of frequent heartburn occurring 2 or more days a week.
At a glance
| Generic name | Prilosec OTC™ Tablets |
|---|---|
| Sponsor | Bayer |
| Drug class | Proton pump inhibitor |
| Target | H+/K+ ATPase |
| Modality | Small molecule |
| Therapeutic area | Gastrointestinal |
| Phase | Phase 3 |
Mechanism of action
It does this by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. This leads to a decrease in gastric acid secretion, which can help alleviate symptoms of acid reflux and heartburn.
Approved indications
- Treatment of frequent heartburn occurring 2 or more days a week
Common side effects
- Headache
- Diarrhea
- Abdominal pain
- Nausea
- Flatulence
- Dizziness
- Fatigue
Key clinical trials
- Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036) (PHASE4)
- Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prilosec OTC™ Tablets CI brief — competitive landscape report
- Prilosec OTC™ Tablets updates RSS · CI watch RSS
- Bayer portfolio CI